Oct 7, 2020
The COVID-19 pandemic has devastated the world on a scale not seen in a hundred years. As we enter the final months of 2020, with cases and deaths continuing to rise across the US, researchers are working round the clock to find a vaccine. Here at Fenway Health, we have recently been activated as a trial site for CoVPN 3502, a new COVID-19 antibody study. How can antibodies be used to potentially stop the spread of COVID-19? Let’s take a look.
This episode's guest is Dr. Kenneth H. Mayer, Medical Research Director at Fenway Health and Co-Director of The Fenway Institute.